Target intelligence / Profile preview

Mediator of RNA polymerase II transcription subunit 6 (MED6)

Target
MED6
Molecular classification
Transcription coactivator, Mediator complex subunit, Other
01

Overview

Mediator of RNA polymerase II transcription subunit 6 (MED6) is a highly conserved protein that is a core component of the Mediator complex, an essential multi-subunit coactivator that regulates transcription of nearly all RNA polymerase II-dependent genes in eukaryotes[4][7]. MED6 functions as a critical interface between the head and middle modules of Mediator, relaying regulatory signals from transcriptional activators to the core transcriptional machinery[1][5]. It is essential for conformational changes and the functioning of the Mediator complex during transcriptional activation, and its disruption impairs the postrecruitment steps of gene activation[1][3][5]. Mutations in key domains of MED6 abolish cell viability in model organisms, highlighting its importance in gene expression regulation. While MED6 has aliases linked to cancer antigens (e.g., NY-REN-28), current data suggest it is fundamentally a structural and regulatory transcriptional coactivator, not a direct druggable target or receptor[7].

Other names
ARC33hMed6NY-REN-28Activator-recruited cofactor 33 kDa componentRenal carcinoma antigen NY-REN-28CTD-2540L5.5
02

Biological functions

Transcriptional activationRegulation of RNA polymerase II transcriptionSignal relay within MediatorCell viability (in yeast)Other
03

Disease associations

Cancer (notably renal carcinoma antigen NY-REN-28)Other

Beyond the preview

Go deeper on Mediator of RNA polymerase II transcription subunit 6 (MED6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator of RNA polymerase II transcription subunit 6 (MED6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call